Legal Representation
Attorney
Jonathan D. Reichman, Esq.
USPTO Deadlines
Next Deadline
1240 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-04-04)
Due Date
April 04, 2029
Grace Period Ends
October 04, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 14, 2023 | FINV | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Jul 21, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Jul 21, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jul 4, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Apr 18, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Apr 4, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 4, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Mar 29, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 29, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 4, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Jan 24, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Jan 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 4, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Jan 4, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 28, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 14, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 14, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 14, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 12, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 12, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 12, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 12, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 12, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 5, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Jun 14, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jun 14, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| May 14, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| May 13, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 6, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 5, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 1, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 28, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, small molecules therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical and medical preparations and substances for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; medical and pharmaceutical chemical preparations for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; pharmaceutical preparations for RNA targeted therapeutics; therapeutic agents for acting on protein targets that regulate translational control of gene expression
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceuticals, namely, small molecule therapeutic preparations for the regulation of mRNA translation and mRNA biology, used in the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; research and development of pharmaceutical preparations; pharmaceutical drug development services; providing scientific research information in the field of pharmaceuticals and molecular biology; research, analysis, and development in the field of pharmaceutical; research and development in the field of bio-therapeutics for the treatment of fibrosis, cancers, neurological diseases, infectious diseases, genetic diseases, and other diseases; scientific investigations for medical purposes; pharmaceutical, medical and scientific research, and development; drug development and discovery; scientific and technological services and research relating to the field of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTECH"